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AN EVALUATION OF THE TREATMENT MODALITY AND MANAGEMENT OF 
OPIOID THERAPY IN ACUTE AND CHRONIC LOW BACK PAIN INDIVIDUALS 
IN RURAL SOUTHEAST  
 
 
An Abstract of the Scholarly Project by 
Michele R. Carey 
 
 
      Roughly 25 million American adults experience pain, and 23 million others 
withstand severe assiduous pain that is disabling and results in decrease work 
productivity, loss of quality of life and diminished health (Meldrum, 2016).  Treatment of 
pain, including chronic and acute low back pain includes a multidisciplinary approach 
merging cognitive-behavioral, psychological and physical therapies, respite, pain coping 
management and self-hypnosis (Meldrum, 2016).  In 1999, pharmaceutical companies 
reassured physicians that opioid pain relievers were not addictive, and the prescribing 
rate began to increase (NIH, 2017).  
The quantity of opioids being prescribed has quadrupled since 1999 which has led 
to an increase in diversion and misuse of these medications, thereby increasing the 
overdose rate from opioids.  This abuse and addiction to opioids has become a crisis of 
epidemic proportions in the US with deaths from overdose now a leading cause of injury 
death (APSE issue Brief, 2015).  The most addictive of these medications such as 
hydrocodone and oxycodone, are routinely used for a variety of conditions, yet guidelines 
for the prescribing of opioids suggest that alternate treatment may be equally effective 
but are not being used.  This opioid epidemic appears multi-factorial including incorrect 
prescribing, illicit and licit drug resources and patient non-adherence.       
Opioid abuse is a significant preventable public health threat challenging our 
country.  This educational scholarly project looks at the prescribing practices of 
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providers in a set of clinics in Southeast Kansas.  The purpose of this study was to 
discover if providers within these clinics followed the recommended CDC guidelines.  
The guidelines include a trial of non-pharmacological, non-opioid therapy to manage 
acute and chronic back pain before initiating opioid therapy, whether they obtained a 
controlled substance agreement, checked the prescription drug monitoring program 
and obtained a urine drug screen prior to prescribing opioids.  The information 
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Roughly 25 million American adults experience pain, and 23 million 
others withstand severe assiduous pain that is disabling and results in decreased 
work productivity, loss of quality of life and diminished health (Meldrum, 2016).  
Treatment of pain including acute and chronic back pain should incorporate a 
multidisciplinary approach merging cognitive-behavioral, psychological and 
physical therapies, respite, pain coping management and self-hypnosis (Meldrum, 
2016). The primary cause of accidental deaths in the United States is drug 
overdose with opioid addiction as the driving force (ASAM,2016). Four out of 
five individuals that use drugs, often begin with opioid pain relievers and then 
turn to the use of heroin due to cost and ease of buying. (ASMA, 2016). 
Description of Clinical Problem  
In 1999, pharmaceutical companies reassured physicians that opioid pain 
relievers for the use of acute or chronic pain, were not addictive, and the 
prescribing rate began to increase (NIH, 2017). The quantity of opioids being 
prescribed has quadrupled since 1999 which has led to an increase in diversion 




from opioids, yet the amount of pain that Americans have reported has not 
increased (NSDUH, 2014).    
This abuse and addiction to opioids has become a crisis of epidemic 
proportions in the US with deaths from overdose now a leading cause of injury 
death (APSE issue Brief, 2015), creating a critical and perplexing public health 
problem.  The most addictive of these medications are routinely used for a variety 
of conditions, yet guidelines for the prescribing of opioids suggest that alternate 
treatment may be equally effective.  Alternate therapies are not routinely used: 
non-pharmacological approaches with non-steroidal anti-inflammatories and 
acetaminophen coupled with physical therapy and self-care instructions.  A 
fundamental concern with prescription opioid associated morbidity and mortality 
is the significant number of individuals that have reported use of nonmedical 
prescription drugs, without a prescription or use to obtain a reaction or experience 
the drug causes (APSE Issue Brief, 2015).  This opioid epidemic appears multi-
factorial including incorrect prescribing, illicit and licit drug resources and patient 
non-adherence. 
Significance  
Opioids such as morphine, methadone, oxycodone and hydrocodone are 
the most widespread drugs.  Opioid abuse is a significant preventable public 
health threat challenging our country. To date, the death toll has exceeded more 
than 600,000, with 180,000 more predicted by 2020 (Gostin et al., 2017).  
According to the American Society of Addiction Medicine (ASAM, 2016), 20.5 




2015, two million were dependent on prescription pain relievers, 591,000 engaged 
in substance abuse that included heroin, and they predict that more than 20% of 
persons that abuse heroin will develop an addiction to opioids (AMSA, 2016). In 
response to this situation, President Trump has declared a national emergency on 
the drug addiction and opioid crisis.  The national emergency affirmation 
acknowledges community health powers, activates resources and authorizes 
advanced tactics to reduce a public health crisis that is accelerating rapidly 
(Gostin et al., 2017). 
Cultivating a change in how opioids are ordered with clinical practice  
guidelines safe-guards clients with more secure and successful chronic pain 
treatment and minimizes the risk of opioid use disorder (CDC, 2017). Improving 
public health prevention nation-wide would aid in a reduction of death and 
morbidity and be cost effective as well (Gostin et al., 2017). The CDC 
recommends nonpharmacological and nonopioid pharmacologic treatment as the 
desired therapy for individuals with unceasing pain.   
Constant pain afflicts more than 10% of US adults and millions are treated 
with prescription opioids, making opioids the most ordered prescription 
pharmaceuticals; they are also highly addictive (Gostin et al., 2017).  Mortality 
related to opioids has risen more than 150% from 21,088 in 2010 to 33,091 in 
2015, reducing the life expectancy of users (Gostin et al., 2017).  Teen overdose 
deaths went from 649 in 2014 to 772 in 2015; an increase of 19%.  The rampant 




2017).  Patients in the US use almost 100% of all hydrocodone and more than 
80% of all oxycodone worldwide (Manchikanti, 2013). 
Close to 250 million opioid prescriptions for pain were written by 
providers in 2013, and one out of four patients on prolonged opioid treatment in 
primary care were struggling with opioid use disorder (CDC).  During the data 
collection, the CDC found 20,000 deaths in 2015 related to prescription opioids 
equaling about 62 deaths per day.  The National Center for Health Statistics 
(NCHS, 2015) revealed the sales of opioid painkillers quadrupled from 1999-
2010, and deaths related to opioids had also tripled from 1999-2012. Data 
collected in 2015 revealed that $250,000 adolescents were nonmedical users of 
pain relievers, and nearly half were addicted to pain relievers (ASMA, 2016).   
The state of Kansas is comparable to the national numbers with KDHE 
reporting a threefold increase in drug hospitalization from 1999-2009, with deaths 
caused by opioid analgesics rising threefold from 1999-2010 (KDHE, 2014).  The 
age-adjusted rate for acute drug poisoning among Kansas residents was slightly 
lower than the CDC’s Healthy People 2020 target at 10.6 deaths per 100,000 
compared to 11.3 per 100,000 (KDHE, 2014).  Southeast Kansas rose above all 
states with the highest age-adjusted rate of death from acute drug poisoning in the 
state, with 13.4 deaths per 100,00 between 2009-2013, while Southwest Kansas 
having the lowest age-adjusted rate of 5.7 deaths per 100,00 (KDHE, 2014).  Men 
had an age-adjusted rate of 11.6 per 100,000 compared with women at 9.6 per 
100,000, while white non-Hispanics held the highest age adjusted death rate at 




Opioids, such as morphine, methadone, oxycodone and hydrocodone were 
the most widespread drug, with 41.1% of drug related deaths, followed by 
Pyschostimulants, which include methamphetamine were the second most 
prevalent, at 7.5% of deaths between 2009-2013. Because a significant number of 
drug deaths were the result of multiple drugs, known and unknown, or at least 
alcohol and one drug, meaning that any drug death could be due to more than one 
drug as a contributor, these numbers do not equal 100% (KDHE, 2014).   
APRNs are among the healthcare professionals that are in a position of 
changing these numbers by thwarting improper access.  To ensure sound 
appropriate prescribing, APRNs must consider using these drugs for legitimate 
purposes and curtail dangerous practices that are contributing to this growing 
crisis.  To effectively incorporate safe practice, actions must focus on both the 
prescribers and the identification of high-risk patients while increasing the 
monitoring of prescription drugs and the sharing of data among providers.  
Clinicians face daunting tasks in assessing pain levels in clients and choosing 
appropriate nonpharmacologic and pharmacologic treatments.  Once the decision 
to begin opioid therapy has been made, appropriate monitoring of therapy for 
abuse prevention and diversion can be equally intimidating (Carter, 2017).  
            Description of Clinical Issue 
          Pain can affect every individual and it is challenging yet unique for each 
person and afflicts the lives of more than 100 million Americans (Institute of 
Medicine, 2011). Knowledge and educational limitations of health care 




Medicine (IOM) 2011 reports that only half of primary care providers (PCPs) feel 
somewhat prepared while 27% report feeling somewhat unprepared or 
underprepared to treat individuals with chronic pain. 
            Prior to 2016, when the CDC sent out 12 suggestions for opioid use in 
chronic pain, there were relatively few guidelines to which providers could refer.          
These guidelines include: use of nonpharmacologic therapy and nonopioid 
pharmacologic therapy as first line treatment to include ibuprofen, Tylenol, ice, 
heat, physical therapy or a combination of each, education provided to patients 
regarding goal expectation and opioid use-risks versus benefit, if an opioid was 
prescribed, was it before or after conservative management, choice of opioid and 
dose provided, use of a controlled substance agreement, use of prescription drug 
monitoring programs (PMDP) and periodic drug screenings to verify compliance 
and deter abuse and misuse.  
            The CDC’s recommended guidelines mirrored guidelines made by the 
American Society of Interventional Pain Physicians Guidelines (ASIPP, 2017) 
related to the safe, responsible, and effective prescription of opioids for 
unrelenting non-cancer pain.  Both the CDC recommendations and the guidelines 
put out by ASIPP state that nonpharmacological and nonopioid pharmacologic 
therapy are the desired choice for prolonged pain.  The CDC recommendations 
are voluntary and do not replace the clinical decision-making discussion between 
the provider and the patient according to the situation, functional status and 
quality of life.  The ASIPP guidelines are recommendations on the actions that 




therapy and different groups of people. The recommendations are aimed at family 
practice, internal medicine, nurse practitioners and physician assistants, who are 
among the top four prescribers of opioids (Laxmaiah et al., 2017). 
               The US financial burden for more than 100 million Americans suffering 
from pain is estimated to be more than $500 billion per year, and this number 
does not include children suffering with pain and those in long-term care 
facilities.  Back pain ranks in the top five most common complaints for all 
provider visits.  Approximately, one fourth of adults expressed having back 
“pain” a minimum of one day in the last ninety days (Chou et al., 2007).  Many 
occurrences are self-limiting, but one third of people have persistent back pain 
one year after an initial event, and one out of five persons indicate significant 
activity limitations (Chou et al., 2007).  Many individuals seeking medical care 
for back pain are unable to link it to a specific cause or abnormality.  
             Impairment in daily functions of life related to chronic pain is a leading 
cause of outpatient visits, specifically, chronic back pain (Keller, 2012).  
Individuals that suffer agonizing injuries often develop longstanding chronic pain 
(Keller, 2012).  Some people will develop chronic pain syndrome with is a 
constellation of symptoms including, sleep disturbance, emotional lability, 
depression, isolation from other, diminished functional capacity and character 
changes (Keller, 2012).  Chronic pain unrelated to malignancy is one of the most 
common and incapacitating medical conditions that is both contentious and 
convoluted to control (Volkow, 2016).  Low back pain is concomitant with 




overall population (Azevado, 2015).  Acute low back pain is pain lasting less than 
six weeks duration and becomes chronic low back pain when it exceeds three 
months duration.   
             Complex treatments, diverse approaches and available resources that can 
be utilized in determining acceptable practice prove to be challenging for 
providers.  Each case is evaluated on its merit and circumstances.  Clinicians need 
to consider both the benefit and the risk of opioid therapy for the patient, 
identifying outcome expectations with the client’s current level of function.  The 
benefit of receiving opioid therapy should be weighed against the potential risk, 
including sedation, tolerance, dependence and confusion.  Evidence supports 
common safety practices and indicators provide guidance in the assessment, 
intervention and safe prescribing of opioids.  Providers cannot be responsible for 
patient actions once they leave the office, but it is the providers’ obligation to 
make opioid use as safe as possible.  Standards of care (SOC) have been 
implemented and endorsed to protect the patient and the public from opioid 
misuse and the provider is responsible for adhering to these standards (Hudspeth, 
2016).    
             Screening tools are useful in identifying persons at high risk for abuse or 
medication misuse.  These tools are aimed at identifying individuals who 
currently use substances such as tobacco or alcohol, individuals who use other 
people’s medications, have mental or mood disorders, those experiencing 
problems with employment or in their family circle and individuals with a 




crimes such as driving under the influence.  There are multiple screening tools 
such as Opioid Risk Assessment (ORT), and the National Institute on Drug Abuse 
(NIDA), and SOAPP-R (Screener and Opioid Assessment for patients with Pain-
revised), and these tools are available as apps that can be downloaded to a smart 
phone for ease of use.   
               It is important to remember that risk assessment tools are not wholly 
consistent or accurate in their prediction of opioid misuse or abuse.  Risk 
evaluation and mitigation strategies (REMS) have been approved by the Food and 
Drug Administration (FDA) but have not been evaluated to be effective (Dowell 
et al., 2016).  A favorably sensitive determination for persons at risk for 
medication misuse was found in a single question related to how often the person 
has used alcohol, tobacco, illegal drugs and prescription drugs for nonmedical 
reasons.  Providers must also remember that high-risk individuals can still receive 
opioid therapy with appropriate management and follow up. 
                          Providers have an honorable and legal duty to care for patients including 
 management of their pain, but pain is subjective and creates a sticky predicament 
for providers (Reidl, 2014).  There is great debate among government entities on 
the appropriate treatment of pain with the use of opioids and the identification of 
those at high risk for use and abuse.  Known factors contributing to abuse and use 
include, poverty, unemployment, work injuries, and a lack of education 
(Laxmaiah et al., 2017).  Highly trained NPs or PAs will know the best treatment 
for pain, how to initiate therapy, and monitor such therapy, when additional 




(Carter, 2017), and yet a lack of education and preparation of providers when 
evaluating and monitoring a patient on opioid therapy coupled with known risk 
factors of abuse and use among patients contributes to the ever-growing opioid 
epidemic.  To fully understand the scope of the opioid epidemic in rural Southeast 
Kansas, an evaluation will be completed of how opioids are prescribed and 
whether the appropriate and current suggested recommendations and guidelines 
are being used by clinicians in rural Southeast Kansas.   
Specific Aim/Purpose  
The goal of this scholarly project was to discern the quantity of opioid 
prescription written for acute and chronic back pain in rural Southeast Kansas 
among multiple clinics.  In addition, this project attempted to discover whether 
CDC guidelines had been followed such as the use of UDS and PMDP, and if 
appropriate monitoring of the patient was done in these clinics in Southeast 
Kansas.  This project also noted if clinicians attempted nonpharmacological and 
nonopioid therapy to manage acute and chronic back pain before they initiated 
opioid therapy.  The data gathered was then compared to how Southeast Kansas 
ranks in the number of opioids prescribed compared to other regions in Southeast 
Kansas.  
Theoretical Framework  
There are two theoretical frameworks that were used in this scholarly 
project, Patricia Benner’s from Novice to Expert Model and Nola J. Pender’s 




adequate resources that prepare clinicians to make evidenced based decisions to 
ensure the best treatment for their clients.  This mimics Benner’s (1984) model, 
From Novice to Expert, where clinicians develop skills and understanding over 
time based on a strong foundation in education and personal experiences. 
Clinicians can gather knowledge via research and clinical practices. Nurses must 
initially learn what to look for and how to intervene in a situation, but as they 
move along through their career and consistently gather knowledge, they move 
from a novice to an expert in nursing.  Nurses returning to school for further 
education follow the Novice to Expert plan as well, though they are already 
practicing nurses. These skills are gained through education in a formal setting, 
education in practice, research and clinical practice throughout one’s career.  
Nora J. Pender’s 1982 Health Promotion Model is also appropriate for this 
scholarly project as she considers how surroundings influence the choices 
individuals make and how people search for ways to achieve their dream, but 
obstacles often hinder or entice individuals with items that appear promising.  
Clinicians can improve the health of individuals by being role models and through 
education with health promotion. Southeast Kansas has many individuals living in 
poverty, and if surroundings influence choices and opioid use is higher among 
those in poverty areas, then becoming stewards of the community through health 
promotion will allow clinicians not only learning experiences but the opportunity 
to be role models and improve the life of individuals before chronic illness or 





Figure 1. Patricia Benner’s from Novice to Expert Model Figure 
            










Figure 2. Nola Pender’s Health Promotion Model 
Research Questions  
1).   Are clinicians in selected clinics in rural Southeast Kansas prescribing opioids using 
the current CDC recommendations and guidelines?   
2).  How does Southeast Kansas compare to other regions in Kansas regarding the 






Definition of Key Terms 
     The key terms for the project include:  
Chronic pain- In this project, chronic pain refers to pain lasting longer than twelve weeks 
(Chou et al., 2007).  
Acute back pain refers to pain lasting less than twelve weeks (Hallegraef et al., 2013). 
Opiate medications are powerful prescription medications that are used to reduce pain 
(UpToDate, 2017). 
Opioid Analgesics include: Hydrocodone, Oxycodone, Fentanyl and Morphine Sulfate 
which bind opioid central nervous system (CNS) opioid receptors leading to inhibition of 
ascending pathways altering an individual’s perception and response to pain (UpToDate, 
2017). 
 A “Nurse Practitioner is defined as a certified registered nurse with advanced nursing 
credentials displayed through formal education and training” (American Medical 
Association [AMA], 2009, p.8).  
Physicians Assistants are defined as restricted licensed primary care providers (AMA, 
2009).  
Addiction is a lingering brain disease with frequent relapses characterized by habitual 
pursuit of drugs and use, regardless of dangerous outcomes (Volkow, 2014). 
Tolerance is an adaptive consequence of an exposure to a drug which leads to a need for 








  Logic Model   
The components of the logic model for this project included inputs, 
activities, outputs and outcomes as outlined in Table I. Using a descriptive 
retrospective chart review analysis of data, prescribing practices and treatment 
modalities of physicians, nurse practitioners and physician assistants revealed 
how different data outputs can improve outcomes by revealing safe prescribing 
practices, improved provider collaboration, identifying persons at high risk for 
abuse potential using CDC guidelines, use of a PDMP and random UDS which 































Table 1. Logic Model  
Inputs Activities  Outputs                            Outcomes (Impact)  







































Safe Prescribing          Use of 
                                  CDC guidelines           Patient 
                                                                          Safety 
 
Improved                       Use of PMDP                                                
Provider                                                                
Collaboration                 Use of random          
                                            UDS                            
 
Identification for 
High risk  
Abuse Potential                 Improved  
                                      Patient Education 
 
                                      Improved Provider  
                                         Education 
 
 
                                                                     
Summary 
Chronic pain is a public health issue and a medical condition that denotes 
physical, cognitive and emotional consequences (Leonardi, 2015).  It is a 
multifactorial concern that often goes under-treated or untreated and is the 
number one presenting complaint in various practice settings from the emergency 




pain management, yet the rate of addiction and overuse of opioids has resulted in 
an epidemic in the United States with ramifications that can last a lifetime.  
NPs and PAs are capable of pain management and must include a 
multidisciplinary, multimodal approach but they need additional formal training 
in both management of pain and pain medications coupled with clear guidelines to 
follow during the initiation of and monitoring of pain management. While many 
states require education for pain management, it will take more than two hours of 
continuing medical education to understand both how to treat and the risks of the 
medications that are being used (Raj, 2017). 
Treatment of chronic pain is vital both clinically, and ethically and opioids 
have a place as a treatment modality however, pain is a complex disorder and 
requires a team approach.  NPs and PAs must feel comfortable with appropriate 
training and guidelines along with risk assessment tools for the safe prescribing of 
opioids in pain management.  Provider practices can be influenced by where they 
practice, and their knowledge and comfort with pain management modalities 
which include opioid therapy, can allow providers to deliver safe and effective 
care.   
Opioid use, abuse, and diversion has reached epidemic proportions in the 
US.  To attempt to correct this issue, this researcher is hoping to find out if 
providers are contributing to the problem.  Pain is the fifth vital sign and 
providers are expected to adequately treat a patient’s pain (Hudspeth, 2011); 
however, provider anxiety when prescribing opioids may inadvertently contribute 




successful in the treatment of acute and chronic pain, yet more and more 
individuals and prescribers are relying on opioids which exacerbates the problem.   
This researcher hoped to determine the current prescribing practices of 
acute and chronic back pain patients by providers in rural Southeast Kansas.  This 
researcher hoped to elicit if providers had prescribed opioids by following the 
recommended CDC guidelines using PMDPs and urine drug screening.  The use 
of this data will improve provider compliance with the use of evidence-based 
opioid prescribing and monitoring for patient abuse and diversion.  Increasing 
education of the patient on the pathophysiology of pain and appropriate therapies 
may begin to decrease the opioid consumption in the US, reducing the economic 






































Introduction Literature Review 
 
        
        A review of the literature was performed utilizing the following search 
criteria: opioid abuse and misuse, therapy for chronic low back pain, pain 
management with the use of opiates, best practice evidence in pain management, 
tools for treating back pain, the addict’s point of view, prescribing practices 
among providers and education in treatment of back pain, the public opinion on 
opioid use, substance abuse, pain management and provider knowledge on pain 
management.  The review of literature will include proposals from medical 
professionals in diverse specialties to determine collective thoughts of 
professionals involved in the treatment of pain.  This literature will incorporate 
recommendations from the CDC, the FDA and the American Society of 
International Pain Physicians (ASIPP) concerning appropriate opioid prescribing 
practices, short and long acting opioid use and when it is appropriate to continue 
long term opioid therapy.   
       This literature review suggests that there is a lack of knowledge and 
training in various pain treatment areas and how best to treat non-malignant 
cancer pain with opioids (Harris et al., 2008).  As chronic pain (CP) is the most 




practitioners (NPs) and physician assistants (PAs) are asked to manage chronic 
pain in the primary setting yet face formidable challenges in selecting appropriate 
nonpharmacological and pharmacologic therapies, when a patient needs an opioid 
and then how to provide ongoing monitoring to curtail abuse and diversion 
(Carter, M., 2017).   
          Musculoskeletal disorders are the most frequent cause of disability in 
developed countries and account for about 3% of the cost of the gross domestic 
product in the United States (Watson & Shay, 2010).  Low back pain is a familiar 
complaint and exemplifies a substantial burden in patient suffering and costs 
(Watson & Shay, 2010).  As musculoskeletal disorders increase as individuals 
age, it is logical to presume that individuals with chronic disability will also 
increase.  Low back pain is prevalent in about 44-49% of the population with a 
lifetime prevalence between 51-84% (Watson & Shay, 2010).   
             Research suggests primary care providers receive inadequate education on 
how to appropriately manage acute and chronic back pain.  This includes the 
appropriate use of non-pharmacologic treatment modalities, non-opioid 
prescriptions and safe prescribing tools, as well as monitoring opioid use 
(Dowling & Denisco 2012).  Opioid prescribing among ambulatory care settings 
doubled from 8% in 1980 to 16% in 2000 (Manchikanti & Hirsch, 2013).  Lack of 
instruction and preparation in treating pain and opioid prescribing has been found 
to increase the stress level and fatigue among primary care providers and they are 
concerned with the misuse of opioids.  Research also noted four categories in 




secure and successful opioid use, failure to supervise compliance, inappropriate 
choice of opioid and lack of regard for comorbidities (Manchikanti & Hirsch, 
2013).  
             Pathophysiology and Epidemiology of Pain 
              Improper selection of opioids suggests a lack of knowledge on pain itself.  
Chronic pain is a complex interaction of nociceptive, neuropathic or mixed 
pathogenic systems (Leonardi et al., 2015).  Nociceptive pain stems from 
stimulation of the primary afferent nociceptors in the peripheral nervous system in 
response to some assault on the system.  This response is sent to the central 
nervous system which allows the body to recognize damage.  Endogenous opiates 
with serotonin and noradrenaline and others incorporates the perception of pain 
and thus becomes a balance of stimulation and inhibition that depends on 
emotional and behavioral influences (Leonardi et al., 2015).  Neuropathic pain is 
derived from injured tissue that withstands a primary injury or dysfunction in the 
central nervous system. The pain may occur centrally or peripherally, but 
syndromes will differ depending on involved fibers. Neuropathic pain is a 
common ailment in primary care and can be disabling (Leonardi et al., 2015).   
           Data has revealed that chronic noncancer patients are not an identical group 
and often present with biological, psychological and social issues convoluted by 
depression, anxiety, somatoform disorders and substance abuse (Leonardi et al 
2015). An accurate diagnosis of chronic pain means clinicians need to 
characterize the nature of the discomfort and the pathology of pain, which are 




          Addiction is a recurring, relapsing brain disorder categorized by drug 
seeking and use regardless of harmful outcomes.  Addiction results from 
interactions between biological and environmental factors, which increases the 
concerns regarding safety, efficacy and appropriate use of opioids in unrelenting 
noncancer pain clients (Leonardi et al., 2015).  
           Pain Management Education  
              The Association of American Medical Colleges created a survey in 2001  
 demonstrating that less than 4% of medical institutions mandate pain management 
instruction (Bair, 2011).  Most patients suffering from acute and chronic pain are 
treated by their primary care provider due to a lack of pain specialists (Bair, 
2011).  Clinical practice guidelines (CPG) already developed focus on 
monitoring, early detection and treatment of problems and conservative dosing 
and improved patient treatment, yet they are not consistently utilized (Trafton et 
al., 2010).  Training of pain management is often fragmented and learned on the 
job due to the lack of formal education and training (Bair, 2011). 
       Chronic pain management is complicated even for pain specialists and is 
compounded by an individual’s comorbidities.  Providers that do not specialize in 
pain management receive little training in pain and opioid management in the 
primary care setting, where pain is only a piece of serious conditions that need 
addressed during a visit (Trafton et al., 2010).  Clinical mentoring for nurse 
practitioners often does not include hours dedicated to pain management and 
orthopedic specialties (Hudspeth, 2011), which leads to a lack of knowledge and 




(Bair, 2011). An appropriate approach to pain management is through matching 
the analgesics mechanism of action to the underlying pathophysiology of the pain 
(Raffa & Pergolizzi, 2014) providing clinicians with relevant knowledge of pain 
and offering clinical expertise to raise assurance in managing unceasing pain 
(Bair, 2011). 
           Chronic Pain, Opioids and National Surveys 
       Opioids are generally used for treatment of chronic pain often at doses that 
surpass current recommended guideline doses (Gomes et al., 2011).  Addiction 
results from the inherent reinforcing properties of opioids and psychological, 
social and physiologic factors of individuals (Fishbain et al., 2008).  Unrelenting 
pain that drives individuals to seek care is not different among states; however, 
prescribing rates for opioids vary significantly across states (NPA, 2012).  In the 
states with the highest prescribing rates, health care providers penned almost 
triple the opioid prescriptions per person than providers in lower prescribing 
states with lower socioeconomic status and higher levels of unemployment as 
contributing factors (NPA, 2012).  Economic depression may contribute to the 
increase in prescription, sales, abuse, overdose and death of opioids (Galewitz, 
2017).  Where a clinician practices often influences how they prescribe and may 
be influenced by their knowledge and comfort with pain management and 
understanding of treatment modalities which include opioid therapy (NPA, 2012).  
         Among individuals that abuse opioids, many get them free from family and 
friends, and those at a higher risk for overdose obtain them differently than those 




their own prescription, 26% obtain them from friends and family for free, 23% 
buy them from friends and family and 15% obtain them from drug dealers.  The 
individuals that have a higher risk for overdose are four times more likely to 
purchase from a drug dealer or stranger (CDC, 2017).  
            Current Recommendations 
            Unremitting pain is a biopsychosocial disorder that compels integrated, 
multimodal and interdisciplinary management, all elements of which should be 
evidence-based (Choo, 2017).  The treatment for pain classes such as neuropathic 
pain and non-neuropathic pain vary, and clinicians need to differentiate between 
nociceptive and neuropathic pain to appropriately treat the patient (Stones et al., 
2016). 
       Efforts to initiate an integrated multidisciplinary approach to treatment is 
often met with resistance with patients refusing to participate in physical therapy 
(Choo, 2017).  Patients suffering from pain will have difficulty with simple life 
tasks such as washing dishes, using the bathroom and engaging in hobbies, which 
then affects not just social and physical well-being but psychological as well 
(Choo, 2017).  Finding strategies that provide patient autonomy and normalcy 
may improve their control over their pain.  
                  The American Academy of Pain Medicine (AAPM) has acknowledged 
that safe pain treatment amid primary care providers is ranked as one of the top 
five concerns (AAPM, 2012). Treating chronic pain is complex due to the 
perception of pain and its trajectory.  Providers should begin looking at pain with 




being that doing nothing is better than causing harm with medications (Knaggs & 
Stannard, 2017).  
                Opioid therapy has been increasing since the 1990’s for unrelenting 
pain, yet recent research has questioned the safety and efficacy of opioid use for 
unrelenting pain not related to cancer, due to the increased risk of tolerance, 
addiction and hyperalgesia (NIDA, 2016).  Opioid abuse and dependence are 
chronic, extensive multifactorial disorders that lead to detrimental effects on 
individuals and society.  A basic understanding of the mechanism behind the 
disorder can aid in identification of management strategies to prevent and treat 
opioid related disorders (Mistry et al., 2014). 
           The Joint Commission on Accreditation of Healthcare Organizations 
developed new measures to advance pain control, fostering the use of pain scales 
and tools, using pain as the fifth vital sign and raising opioid prescribing and 
pharmaceutical opioid accessibility for nonmedical use and overdose (Paulozzi, 
2011).   
             Providers report inadequate training when managing chronic pain, 
especially in individuals with aberrant behavior (Calcaterra et al., 2013).  
Controlling pain is a central issue in the US with healthcare providers and policy 
makers attempting to abate undesirable effects of increased access to prescription 
opioids while still providing adequate pain control (Brady et al., 2016). 
            Legislative Policy 
Between 1999-2010, an analysis of spine care in the US, showed low use 




risk medications such as opioids promotes concern due to the known issues with 
safety and effectiveness (Krein et al., 2016).  Drug addiction is a social problem 
with individuals feeling the need to take regular doses of substances to feel good 
(Beneitez & Gil-Alegre, 2017).  Slashing the drug supply will not stop this trend; 
however, it is preferred that people be able to confront their lives and learn coping 
mechanisms during stressful situations without drugs, and therefore education is 
so important when it comes to healthcare (Beneitez & Gil-Alegre, 2017).   
The National Health Institute is an influential agency that is leading the 
charge to discover ways to thwart the misuse of opioids, handle opioid use 
disorders and control pain.  This initiative is working toward a partnership with 
pharmaceutical corporations and educational research agencies to cultivate secure, 
effective and non-addictive strategies for pain management.  The initiative also 
looks for inventive ways to treat opioid use disorders, improve deterrence and 
reversal interventions to save lives while providing recovery support.  Refining 
the way in which providers prescribe opioids through clinical practice guidelines 
will guarantee clients have access to safer, more useful treatment of unrelenting 
pain while lowering the risk of opioid use disorder (CDC, 2017), and clinicians 
are committed to using evidence-based practice to identify, interpret and apply 
findings to individuals. Improving public health prevention nationwide would aid 
in a reduction of death and morbidity and be cost effective (Gostin et al., 2017). 
The CDC recommends nonpharmacological and nonopioid pharmacologic 




Drugs will exist continually, and the United States Federal Drug 
Administration (USFDA) program is educating providers on appropriate opioid 
prescribing practices, how to identify patients suited for opioid therapy, and how 
to properly educate individuals regarding use of opioids, storage and disposal 
(Beneitez & Gil-Alegre., 2017).  In 2010, the CDC noted that opioids were 
responsible for more than 16,000 deaths out of 40,00 drug overdose deaths and as 
a result, the FDA published the “Guidance for Industry Assessment of Abuse 
Potential Drugs” explicitly looking at the study and improvement of new 
pharmaceutical technologies with the goal of reducing drug abuse (Beneitez & 
Gil-Alegre, 2017).     
In 2016, the CDC came out with a set of guidelines to aid providers in 
their decision making regarding opioid therapy.  The CDC’s guidelines have three 
main focuses:  initiation of or the continuance of opioid therapy for prolonged 
pain; choice of opiate, dosage, length of use, follow up, discontinuation and 
assessment of risk; and addressing harms of opioid use.   
The foundation for development of these guidelines was the result of 
provider trepidations about opioid drug misuse, overseeing patients with 
protracted pain, apprehension regarding dependence and reports of inadequate 
education in prescribing opioids (CDC, 2016).  Clinician knowledge, prescribing 
practice changes and improved patient health benefit can be achieved with the use 
of clinical practice guidelines concentrating on prescribing opioids (CDC, 2016).        
The CDC is not the only professional organization to release new 




2009.  Washington Agency Medical Directors Group 2015, and the US 
Department of Veterans Affairs/Department of Defense 2010 have also created 
guidelines.  Each of the guidelines impart mutual components including dose 
titration and risk mitigation strategies, yet there is significant variance in specific 
recommendations which may not reflect evidence-based material (CDC, 2016).  
Evidence based guidelines can enhance care and improve patient safety while 
decreasing misuse of opioids (CDC, 2016).  
Opioids are an important piece of acute pain treatment for moderate to 
severe pain, but hazards for chronic use do exist (Streltzer et al., 2008).  The 
American Academy of Addiction Psychiatry came out with a set of guidelines 
when using opioids in unrelenting nonmalignant pain for those who believe in 
their efficacy, hoping to maximize benefits and minimize harm (Streltzer et al., 
2008).  Among their recommendations they note that some state medical licensing 
boards believe the customary practice when using opioids is a reduction in 
symptoms and improvement in functioning, observing that high dose opioids have 
not been proven to be effective, and when used long term they create and increase 
in hyperalgesia or pain sensitivity (Streltzer et al., 2008).  
A two to four weeks trial of opiates for the treatment of acute pain has 
been noted among providers (Tavernise, 2016), and research has noted that there 
is some benefit in pain management if opiates are used less than twelve weeks 
(Dowell et al., 2016).  Current recommended guidelines are to treat pain with 
ibuprofen and aspirin as a first line modality with opiates being used for three 




Chou, (2016), found limited research that opioids are beneficial for long term 
treatment of pain.  Habitual opioid use disorder, death and overdose was implied 
when opioids were given for acute back pain (Dowell et al., 2016).   
Public concern and awareness regarding the negative impact of 
prescription abuse and misuse has grown.  There has been little research done on 
how provider’s views related to the epidemic influences the efforts to address the 
issue, while public health policy makers and researchers study intervention tactics 
(Wright et al., 2016).  
Simple strategies outlined by state policymakers include the electronic 
physician order entry system and the prescription drug monitoring systems 
(PDMP) which document and monitor the use of schedule II-V narcotics (Wright 
et al., 2016). Although these systems are primarily for tracking prescribing 
practices and note potential provider shopping, many of the systems are quite new 
in their development (Wright et al., 2016).  Regardless of the system used, 
research needs to look at how providers view the drug epidemic and how these 
beliefs influence their practice (Wright et al., 2016). 
There have been mixed feelings among providers regarding the strategies, 
as some providers feel that these governmental regulations intrude their practice.  
PMDPs often offer beneficial information back to prescribers to facilitate 
improvement in the quality of their day to day clinical decision making, but they 







Patient’s Satisfaction and Current Clinical Recommendation  
Cautionary use of opioids for pain therapy becomes a challenge as pain 
decreases.  Withdrawal by the patient may be uncomfortable; and, the prescribing 
provider maybe inexperienced in the titration of the opioid, which may lead to 
continued use of opioids even if benefits are minimal and risks are high for 
continued use (Streltzer et al., 2009).  One guideline by the American Academy of 
Addiction Psychiatry allows the provider and patient the use of opioids if they 
believe them to be effective but encourages the thought of how opioids can harm 
some and how diversion may occur (Streltzer et al., 2009).  Abuse, misuse, opioid 
overdose and death have spurred the CDC, National Center for Injury Prevention 
and Control (NCIPC), National Institute for Drug Abuse (NIDA) and the 
Substance Abuse and Mental Health Services Administration (SAMHSA) to 
develop current recommendations after reviewing common practice guidelines 
(Dowell et al 2016). 
Among the eight guidelines the common practices include a complete 
physical exam, thorough pain record, medical history, family and social history, 
urine drug screening and a discussion about the appropriate treatment course.  The 
treatment course should include a discussion regarding use of opiates at the lowest 
dose once alternative treatments have been unsuccessful; the implementation of a 
controlled substance agreement, and a method to monitor treatment and pain 
progress with a plan for safe, effective discontinuation of opioids (Dowell et al., 
2016).   




diverted, with many of the diverted opioids from prescriptions that were written 
by providers (Longo, 2016).  Regardless of the clinical guidelines currently in 
place, they are guidelines and do not replace provider judgement.  A provider’s 
lack of faith in their ability to safely prescribe opioids, the inability to detect 
abuse or dependence and the ability to have an acceptable discussion regarding 
these issues may cloud a provider’s judgement (Longo, 2016).  Individuals have a 
right to have their pain managed in an appropriate manner which may include the 
use of opioids; however, patient rights should be weighed against the danger to 
the individual and society (Cheatle, 2015).  
Research observed a higher incidence of opiate use long term in patients 
that experienced low back pain resulting from injury and those who underwent 
spinal surgery (Dowell et al., 2016).  Individuals who received more than five 
prescriptions for opioids early on for low back pain treatment with up to 140 
morphine milligram equivalents (MME) daily had a higher odds ratio for 
undesirable effects including misuse, overdose and mortality (Dowell et al., 
2016).   
There is no straightforward solution to the epidemic, but research does 
show that advocating for use of opioids at the lowest dose for the briefest amount 
of time, increasing the educational training on both prescribing and the difference 
in tolerance vs dependence, and a better understanding of acute and chronic pain 
would aid providers in safer, more successful pain management and reduce the 





          Financial and Political Implications  
              A leading cause of outpatient visits and functional impairment among 
individuals is unrelenting pain with healthcare cost exceeding $70 billion each 
year (Keller et al., 2012).  Cost to employers, state and federal family assistance 
organizations and attempts to minimize or curtail the use of opiates result in social 
issues such as failure to adequately perform job functions at work, school and 
home (Dowell et al., 2016).  Most guidelines for chronic pain indicate active 
physical interventions such as exercise including manual therapy, core 
strengthening, coordination and endurance and are evidence-based 
recommendations (Azevedo et al., 2015).  While detrimental effects of opioid use 
have been observed, there is limited evidence related to outcomes using clinical 
guidelines (Dowell et al., 2016). 
           Summary 
           Opioid use disorders have raised concerns about the relationship of long-
term opioid therapy and challenged dangerous patterns and impairment (Dowell et 
al, 2016).  Providers have expressed unease when it comes to opioid 
misappropriation and report an increased anxiety in the treatment of unrelenting 
pain with lack of appropriate education in prescribing opiates (Dowell et al., 
2016).   
               Private and governmental agencies funding the costs of disability and 
opiate misuse, abuse, overdose and death would benefit from fiscal prudence.  




Oklahoma and Arkansas) would benefit stakeholders understanding of current 
health practices for the treatment of chronic pain.  This scholarly project aims to 
identify what providers prescribe for chronic low back pain and how or if they 























































Research suggests a lack of knowledge and training in various pain 
treatment areas and treating non-malignant cancer pain with opioids (Harris et al., 
2008).  Nurse Practitioners (NPs) and Physician Assistants (PAs) are asked to 
control chronic pain in the primary setting yet meet formidable challenges in how 
to select appropriate nonpharmacological and pharmacologic remedies. In 
addition, when an opiate is needed these providers are asked to provide continued 
monitoring to curtail abuse and diversion (Carter, 2017).  The purpose of this 
study was to review the prescribing practices of primary care providers in 
Southeast Kansas. The data regarding opioid prescription was then compared to 
opioid use in other regions of Kansas. This study looked at one specific set of 
clinics in Southeast Kansas to discern how providers were treating acute and 
chronic pain and if they were following the recommended CDC guidelines when 
prescribing opioids. 
A major clinical challenge facing the nation is the management of acute and 
chronic back pain.  The overuse of opioids and the abuse potential associated with 
the use of opioids has powered efforts to create a set of guidelines to be used by 





A descriptive retrospective cohort chart review was conducted on thirty 
providers from a variety of clinics in Southeast Kansas.  The aim of this study was 
to discern the quantity of opioid prescriptions written for acute and chronic back 
pain in rural Southeast Kansas among multiple clinics. In addition, this project 
attempted to discover whether the CDC guidelines had been followed such as the 
use of PMDPs and UDS, and appropriate monitoring of the patient was done in 
these clinics in Southeast Kansas.  The number of opioids prescribed in Southeast 
Kansas was then compared to other regions in Kansas.  
Sampling 
A group of clinics in the Southeast Kansas area were used to obtain this 
data on prescribing practices of primary care providers for the treatment of acute 
and chronic back pain.  These clinics serve patients in the four-state area of 
Kansa, Missouri, Oklahoma, and Arkansas (Hudspeth, 2011). 
Eight charts from seven clinics with a total of 30 providers, including 
physicians, nurse practitioners, and physician assistants were reviewed, across a 
variety of specialties within the clinics including internal medicine, family 
practice and acute care. Inclusion criteria for this project were individuals with a 
diagnosis of acute and/or chronic back pain, adults over the age of eighteen and 
individuals that have been prescribed an opioid during their treatment for acute or 




the age of eighteen, pediatric providers and individuals that do not have a 
diagnosis of acute and or chronic back pain.  
Data collection began following approval from the Pittsburg State 
University Irene Ransom Bradley School of Nursing Institutional Review Board 
and the Pittsburg State University Institutional Review Board.  Permission was 
also obtained from the board of the clinics to be used.  Confidentiality was 
maintained by eliminating identifying information regarding patients and 
providers.  
The benefits of the data collection will be identifying areas for 
improvement in the treatment of acute and chronic back pain by the providers in 
the clinics studied.  The chart review sought to reveal which specialties in the 
clinics were utilizing evidence-based guidelines more than the other areas, and 
whether different providers (MDs, NPs and PAs) prescribe more opioids than the 
others. There was no risk to participation in this project as no identifying 
information was used, maintaining confidentiality of both providers and patients.  
Instrument 
A retrospective chart review was conducted on providers in select clinics 
between April 1, 2017 and April 1, 2018.  The survey used was created 
specifically to gather information of basic provider and patient demographics and 
a review of the prescribing practices of the providers.  The data regarding opioid 
prescribing was compared to regional data to identify how Southeast Kansas 




providers were utilizing the CDC’s recommended guidelines when prescribing 
opioids for patients with acute or chronic back pain.   
Procedure 
Demographic information was extracted from each chart to include the 
primary care provider’s gender, age, clinical practice (MD, DO, APRN, and PA), 
years in practice, DEA licensure and area of practice (Family Practice, Internal 
Medicine, or Acute Care).  The data collected included the provider’s 
participation in pain management courses during their educational training or 
continuing education classes since receiving their degree.    
Additional data collected from the chart review included what therapies 
were initiated for the acute and/or chronic back pain, including non-
pharmacological methods.  The chart review also noted whether the provider 
followed a set of evidence-based guidelines for treating the presenting pain and 
subsequent monitoring of the patient, and whether education regarding opiate use 
was provided to the patient.  Data collection covered a one-year time span from 
April 1, 2017 through April 1, 2018.   
To extract the data needed for this project, the researcher requested 
assistance from the quality improvement manager of the clinics.  The quality 
improvement manager decoded any identifying information of both providers and 
patients prior to providing the extracted data to the researcher, thus ensuring 
confidentiality. 
SPSS software was used to compile the information and trends were noted 




were, the use of a contract between the patient and the provider, how they 
monitored the patient for compliance and abuse potential, length of time the 
patient was provided opioids and what opioids were prescribed. Southeast Kansas 
was then compared to other regions in Kansas regarding the number of opioids 
individuals are receiving.  
Analysis 
Following approval from the Pittsburg State University Irene Ransom 
Bradley School of Nursing Institutional Review Board, the Pittsburg State 
University Institutional Review Board and board approval for the clinics, data 
collection took place over four weeks or until all data had been obtained and the 
data collected was from a one-year time frame.  Confidentiality was maintained by 
not using any identifying information regarding patients or providers, and all 
information obtained was securely locked in a cabinet within the researcher’s home. 
Once all the information had been extracted, the data was analyzed using SPSS 
software to answer the questions set forth in Chapter I: 
1) Are clinicians in selected clinics in rural Southeast Kansas prescribing 
opioids using the current CDC recommendations and guidelines?   
2) How does Southeast Kansas compare to other regions in Kansas regarding 
the number of opioids written by providers?   
Assumptions 
The assumptions with this study were that provider documentation was 




monitoring of the patients for abuse risk and accurate documentation of 
alternative modalities used. It was also assumed that anonymity was maintained 
throughout the collection process. An added conjecture was that the information 
extracted was an appropriate representation of provider practices in the four-state 
area (Kansas, Missouri, Oklahoma, and Arkansas) and the surrounding counties. 
Limitations 
One limitation of this study was the limited number of clinics that was 
utilized may not provide a complete representation of all clinics in the area. An 
additional limitation is the short time frame that was used for data collection and 
the small representative sample of providers.  This research may leave the results 
open to inspection regarding provider judgement in therapeutic modality choice 
when it comes to acute and chronic back pain.  Updated treatment modalities 
chosen by providers and updated guidelines that providers are referencing may 
not be adequately identified in this study due to the evolving nature of medicine.  
As this was a chart review, there was no bias in self reporting of therapies chosen 
for the treatment of both acute and chronic back pain.  The intent of this research 
was to identify how providers chose to treat acute and chronic back pain, whether 
they were utilizing a standard set of guidelines, how they monitored the patients 
and whether they were inadvertently contributing to the opioid epidemic.  
           Delimitations 
Provider differences in the treatment of pain and ongoing pain 




be a delimitation in this research.  A chart review would be unable to establish the 
reason for a provider’s clinical judgement when choosing a course of treatment, 
but it would identify if providers are following recommended CDC guidelines in 
their practice.   
Summary 
This research will help identify the current practices of local healthcare 
providers when treating acute and/or chronic back pain.  It will note whether 
providers are doing due justice and following the CDC’s recommended guidelines 
when providing opioids for pain management, in addition to utilizing tools to 
mitigate abuse potential, and identify individuals at risk for opiate abuse.  This 
research also aimed to recognize whether providers used nonpharmacological 






































More than 20 million American adults suffer from pain, and 
approximately 23 million more suffer from chronic relentless pain leading to 
disability, loss of work productivity, diminished quality of life and diminished 
health status (Meldrum, 2016).  The economic burden of this is more than $500 
billion annually, not including pain in children, individuals residing in long-term 
care facilities, military persons and prisoners (Pizzo, 2012). The cost for pain in 
the U.S. related to lost wages and medical care exceed the cost for cancer, heart 
disease and diabetes collectively (Pizzo, 2012).  
An integrative approach with physical therapy, psychological, mental and 
physiological therapy, relaxation, coping methods and self-hypnosis are the best-
known alternatives to opioids (Meldrum, 2016).  Educating clients on adaptive 
habits to manage incapacitating consequences of their ailment is critical for 
efficacious management of pain (Peters, 2017).  Individuals need to learn coping 
mechanisms to manage taxing life events without the use of drugs and education 
is paramount.  
The year 2016 brought a request for change by The Physicians for 




implore upon the Joint Commission for Accreditation of Health Care 
Organizations, to stop the compulsory pain assessment implying that it promotes 
hazardous pain control practicing (Meldrum, 2016).  While this request did bring 
about some changes in prescribing practices for nonacute, nonterminal pain, it has 
also sparked new debates regarding pain management. The initial campaign from 
pharmaceutical companies that opioids were safe and not addictive was no longer 
found to be true. Pharmaceutical manufacturers adept at targeting markets of 
individuals, benefits to insurance carriers and creative free enterprise among drug 
traffickers brought proof that opioid use and accessibility often led to lethal 
consequences (Meldrum, 2016).  
The United States continues to see an increase in the opioid epidemic, and 
intricate tactics will be needed to pursue developing perils and respond 
appropriately.  More than 200 million opioid prescriptions were distributed from 
retail U.S. pharmacies in 2016 (Throckmorton, 2018). Preventing new addiction 
through educational improvements regarding opioid prescribing and promoting 
the use of non-opioid pain medications are just a couple of ways to tackle the 
destructive influence of the opioid epidemic.   
As chronic pain is so pervasive it is unrealistic and unfavorable to expect 
pain specialists to manage all pain for patients with less than 4000 specialists in 
the country (Pizzo, 2012).  It is also unreasonable to expect primary care 






Purpose of the Study 
The purpose of this scholarly project was to discern the quantity of opioid 
prescriptions written for acute and chronic back pain in rural Southeast Kansas 
among multiple clinics.  In addition, this project would discover whether CDC 
guidelines had been followed such as the use of UDS and PMDP, and appropriate 
monitoring of the patient in these clinics in Southeast Kansas.  This project noted 
if clinicians attempted nonpharmacological and nonopioid therapy to manage 
acute and chronic back pain before they initiated opioid therapy.  These numbers 
would be compared to other regions in the state of Kansas to determine how 
Southeast Kansas is contributing to or changing the opioid crisis.   
Research Questions  
The research questions for this scholarly project were: 
1) Are clinicians in selected clinics in rural Southeast Kansas prescribing 
opioids using the current CDC recommendations and guidelines?   
2) How does Southeast Kansas compare to other regions in Kansas regarding 
the number of opioids written by providers?   
Study Results 
This was a retrospective chart review on seven small rural Southeast 
Kansas clinics. A total of eight charts among 30 providers in the clinic were 
reviewed totaling 240 chart reviews, and basic provider demographics were 
obtained.  Provider demographics included: provider degree (MD, DO, NP, PA), 




specialty, and if the provider had specific pain management education with their 
formal training or if they had participated in any continuing education courses 
related specifically to pain management.  Please refer to Tables 2-7, and 
Histogram 1 and 2.  
Provider Demographics 
Table 2. Clinic Location 
 Frequency Percent 
 Pittsburg 104 43.3 
Parsons 24 10.0 
Independence 8 3.3 
Iola 40 16.7 
Columbus 16 6.7 
Coffeyville 24 10.0 
Baxter Springs 24 10.0 
Total 240 100.0 
  
Table 1 shows the number of charts provided from each clinic for review.  Over 43.3% of 
all charts came from a clinic in Pittsburg.  
(240= the number of charts reviewed in total- 8 charts per provider) 
Table 3. Provider 
 Frequency Percent 
 Medical Doctor 80 33.3 
Doctor of Osteopathic Medicine 8 3.3 
Nurse Practitioner 128 53.3 
Physician Assistant  24 10.0 
Total 240 100.0 
 
Table 2 shows that more than 50% of the providers were Nurse Practitioners followed by 






The average age of the providers was 48.5 years (SD = 15.17). The histogram indicates a 
larger proportion of providers that were 40 years or less.  
Table 4. Provider Gender 
 Frequency Percent 
Valid Male 64 26.7 
Female 176 73.3 
Total 240 100.0 
 








The average number of years the provider has been in practice was 12.3 years (SD= 
14.032). The histogram indicates that more providers have been in practice less than 
fifteen years.  
Table 5. DEA Licensure Current 
 
                                                                            
Frequency Percent 
 Yes 240 100.0 
 






Table 6. Provider Specialty 
 Frequency Percent 
 Internal Medicine 40 16.7 
Family Practice 168 70.0 
Acute Care 32 13.3 
Total 240 100.0 
 
Table 5 indicates that less than 75% of the providers practice in Family Medicine and less 
than 20% practice in Internal Medicine.  
 
Table 7.  Pain Management Education in Training 
 Frequency Percent 
 Yes 8 3.3 
No 56 23.3 
Total 64 26.7 
Missing  176 73.3 
Total 240 100.0 
 
Note:  Missing values were due to providers that did not provide a response to the 
question.  
Table 6 indicates that slightly less than one quarter (23.3%) of providers did not get 















Table 8. Continuing Education in Pain Management 
 Frequency Percent 
 Yes 48 20.0 
No 16 6.7 
Total 64 26.7 
Missing  176 73.3 
Total 240 100.0 
 
Note: Missing values were due to providers not giving a response to the question.   
 
Of the providers that did answer the question, one-fifth (20%) of them have taken some 
continuing education course in pain management since beginning practice. 
           Patient Demographics 
Basic demographic information from each patient chart that was also 
obtained and reviewed.  To be included in the study; each chart had to have a 
diagnosis of acute or chronic back pain.  Patient information obtained included 
patient age, patient gender, patient ethnicity and whether they were insured, 
uninsured or underinsured.  During the chart review, it was found several times 
that although the patient may have come in to be seen for an acute or chronic back 
pain, the diagnosis given was “other chronic pain”.  Please refer to tables 9-11 and 
Histogram 3.  
Table 9. Diagnosis of Acute or Chronic Pain? 
 Frequency Percent 
Valid Yes 240 100.0 
 
100% of the charts reviewed had a diagnosis of acute or chronic back pain which was 







The average age of the patient was 48.07 years (SD=13.916).  The largest grouping of 
individuals tended to be in the range of 50-60 years of age. 
Table 10. Patient Gender 
 Frequency Percent 
 Male 110 45.8 
Female 130 54.2 
Total 240 100.0 
 






Table 11. Patient Ethnicity 
 Frequency Percent 
 Caucasian 193 80.4 
Hispanic 8 3.3 
African American 10 4.2 
Native American 10 4.2 
Caucasian/Hispanic 2 .8 
Total 223 92.9 
Missing  17 7.1 
Total 240 100.0 
 
Note: Missing values were due to patients that did not answer the question regarding 
ethnicity.   
More than three-fourths of the patients identified themselves as Caucasian, followed by 
4.2% identifying as African American or Native American, 3.3% identifying as Hispanic 
and 0.8% identifying as both Caucasian and Hispanic. 
Table 12.  Insurance 
 Frequency Percent 
 Insured 169 70.4 
Uninsured 71 29.6 
Total 240 100.0 
Total 240 100.0 
 
Close to three-fourths (70.4%) of the patients did have some type of insurance. 
  
Research Questions 
1) Are clinicians in selected clinics in rural Southeast Kansas prescribing 




2) How do the statistics pertaining to opioid use for treating acute and 
chronic back pain in the selected clinics compare to other regions in the 
state of Kansas?  
Please refer to Tables 13-20 for data related to practice question one. 
Table 13.  Were CDC Guidelines Followed? 
 Frequency Percent 
 Yes 188 78.3 
No 52 21.7 
Total 240 100.0 
 
More than three-fourths (78.3%) of the providers were following CDC guidelines.  
 
Table 14. Did Provider Start with Conservative Management: Ice/Heat/ 
Ibuprofen/Tylenol/Steroids-Physical Therapy or a combination of 
conservative treatment? 
 Frequency Percent 
 Yes 197 82.1 
No 43 17.9 
Total 240 100.0 
 
More than three-fourths (82.1%) of the providers began with conservative management 





















 Yes 33 13.8 
No 81 33.8 
Total 114 47.5 
Missing  126 52.5 
Total 240 100.0 
 
Note: Missing value were because the provider was following guidelines and did not 
prescribe opioids.  
A little more than one-tenth (13.8%) of providers prescribing opioids provided education 
to the patient, with one-third (33.8%) of the providers not providing patient education 
regarding the use of opioids.  
Table 16. If an Opioid was prescribed by the Provider- was it before or after conservative 
therapy? 
 Frequency Percent 
 Before 56 23.3 
After 56 23.3 
None Prescribed 128 53.3 
Total 240 100.0 
 
There was an equal split with just less than one fourth of providers prescribing opioids 
(23.3%) before conservative management and just less than one fourth (23.3%) 
prescribing opioids after conservative management, while slightly more than one-half 




Table 17.  Once the opioid was prescribed: Did provider obtain a Controlled 
Substance Agreement? 
 
 Frequency Percent 
 Yes 69 28.7 
No 44 18.3 
Total 113 47.1 
Missing  127 52.9 
Total 240 100.0 
 
Note: Missing values were because the Provider did not prescribe opioids.   
 
Of the providers that chose to prescribe opioids, more than one-fourth (28.7%) 
providers obtained a Controlled Substance Agreement.  
Table 18. Did provider consult a Prescription Drug Monitoring Program? 
 Frequency Percent 
 Yes 46 19.2 
No 67 27.9 
Total 113 47.1 
Missing  127 52.9 
Total 240 100.0 
 
Note:  Missing values were due to providers not prescribing opioids for acute/chronic 
back pain.  
Of the providers that chose to prescribe an opioid, more than one-fourth (27.9%) did not 
consult the Prescription Drug Monitoring Program prior to prescribing the opioid, with 
less than one-fifth (19.2%) consulting the Prescription Drug Monitoring Program prior to 




Table 19. Did the provider obtain a urine drug screen? 
 Frequency Percent 
 Yes 71 29.6 
No 42 17.5 
Total 113 47.1 
Missing  127 52.9 
Total 240 100.0 
 
Note:  Missing values were due to providers not prescribing opioids.   
 
Of the providers that did prescribe opioids, more than one-fourth (29.6%) of them 
obtained a urine drug screen, while less than one-fifth (17.5%) of providers did 
not obtain a urine drug screen. 
Table 20. What opioid was prescribed? 
 Frequency Percent 
Valid Hydrocodone/Oxycodone 99 41.3 
Fentanyl 2 .8 
Morphine 5 2.1 
Both Hydrocodone and Morphine 5 2.1 
Fentanyl and Morphine 1 .4 
Total 112 46.7 
Missing  128 53.3 
Total 240 100.0 
 
Note: Missing values were due to providers not prescribing opioids  
 
More than one-half (53.3%) were missing which means that the prescriber did not 
prescribe opioids. Of the opioids prescribed, less than one-half (41.3%) of the opioids 










Table 21. Dose of Opioid 
 Frequency Percent 
               Hydrocodone/Oxycodone    5/10 mg 99 41.3 
Morphine                             5/10/15/30mg 5 2.1 
Morphine/Hydrocodone/Oxycodone 5 and 5 5 2.1 
 Fentanyl/Morphine             50 and 30 1 .4 
 Total 110 45.8 
Missing  130 54.2 
Total 240 100.0 
 
Note: Missing values were due to providers not prescribing opioids  
More than one-half (54.2%) were missing meaning they did not prescribe opioids.  Of the 
providers that did prescribe an opioid, less than one-half (41.3%) were given either 5 or 10 
mg as an initial dose of hydrocodone or oxycodone, followed by 2.1% being prescribed a 
dose of morphine and 2.1% being provided both hydrocodone or oxycodone and morphine. 
Specific Purpose of the Study 
The goal of this scholarly project was to discern the quantity of opioid 
prescriptions written for acute and chronic back pain in rural Southeast Kansas 
among multiple clinics.  In addition, this project attempted to discover whether 
CDC guidelines had been followed such as the use of UDS and PMDP, and 
appropriate monitoring of the patient was done in these clinics in Southeast 
Kansas.  This project also noted if clinicians attempted nonpharmacological and 
nonopioid therapy to manage acute and chronic back pain before they initiated 
opioid therapy.  These numbers were compared to other regions in Kansas to 









It is no secret that the United States (US) has had a problem with abuse, 
misuse and diversion of opioids for several years.  This issue has been found to be 
multi-factorial, and includes improper prescribing, an assortment of drug 
suppliers both legal and illegal, delayed government reaction and incessant 
advertising for off-label consumption by pharmaceutical companies (Maxwell, 
2010).  
A retrospective chart review was performed to see if providers in several 
rural Southeast Kansas clinics may be contributing to the misuse, abuse and 
diversion of opioids due to inappropriate prescribing practices outside of 
recommended CDC clinical guidelines.  The information obtained would then be 
compared with other regions in the state of Kansas.  
The survey used was created specifically to gather information of basic 
provider and patient demographics and a review of the prescribing practices of the 
providers.  The specific questions addressed was related to the recommended 
CDC clinical guidelines for prescribing opioids being followed within the rural 
Southeast Kansas clinic.  The recommended guidelines being reviewed were 1) 
conservative management of acute or chronic low back pain with non-steroidal 
anti-inflammatory drugs (NSAIDS), acetaminophen, physical therapy, or use of 
ice or heat packs?  2) if an opioid was prescribed, did the provider consult the 
prescription drug monitoring system, obtain a controlled substance agreement 
with the patient, or obtain a urine drug screen prior to beginning opioid therapy? 




opioid was given and at what dose?  4) did the provider educate the client on the 
use of opioid therapy?  5) has the provider received specific training in pain 
management through formal education or taken continuing education courses 
specifically geared toward pain management?  
Provider Demographics Discussion 
There were seven clinics used for this study in the Southeast Kansas 
region.  The clinic in Pittsburg had 43.3% of the practicing providers, Iola had 
16.7% of the providers, the Parsons clinic had 10% of the providers, Coffeyville 
and Baxter Springs had 10% of the practicing providers, and Independence had 
3.3% of the providers. 
The providers were broken down based on degree; 33.3% were medical 
doctors, 3.3% were Doctor of Osteopathic Medicine, 53.3% were nurse 
practitioners and 10% were physicians’ assistants.  The average age of the 
provider was 48.5 years with a standard deviation of 15.17.  There were 26.7% 
male providers and 73.3% female providers and the average number of years in 
practice was 12.3 years with a standard deviation of 14.032.  All the providers 
held a current DEA licensure.  Provider specialties were broken down into 
internal medicine with 16.7% of practicing providers, 70% of the providers 
practiced in Family Medicine and 13.3% practiced in Acute Care.   
Just over 73% of providers did not answer whether they had received any 
formal training in pain management, 3.3% replied that they had received formal 
training and 23.3% reported not receiving any formal pain management 




attended any continuing education courses specifically geared towards pain 
management, 20% replied that they had attended continuing education courses for 
pain management and 6.7% had not taken any continuing education courses.   
Patient Demographics Discussion 
Patient demographic information was also obtained from each patient 
chart.  All charts reviewed had a diagnosis of acute or chronic back pain listed in 
the chart.  The average age of the patient was 48.07 years with a standard 
deviation of 13.916.  The largest age group of the patients was between the ages 
of 50-60 years.  Males represented 45.8% of the patients and female comprised 
54.2% of the charts reviewed.   
Of the charts reviewed, 80.4% of the patients identified themselves as 
Caucasian, 3.3% identified as Hispanic, 4.2% identified as African American, 
4.2% identified themselves as Native American and 0.8% identified themselves as 
Caucasian/Hispanic.  Insured patients comprised 70.4% of the patients while 
29.6% of the patients were uninsured.  
Analysis of Research Questions 
The results of the survey revealed that 78.3% of the providers practicing in 
the clinics were following the recommended CDC guidelines for opioid 
prescribing while 21.7% of the providers were not following the guidelines.  
Conservative management which included the use of NSAIDs, acetaminophen, 




providers chose to use conservative management and 17.9% did not start 
treatment with conservative therapies.   
Patient education regarding the use of opioid therapy revealed that 13.8% 
of the providers educated the patient on opioid use and 33.8% did not provide the 
patient with any education regarding opioid therapy and the 52.5% that did not 
provide education was the result of following CDC guidelines and no opioids 
were being prescribed to the patient. When looking at whether an opioid was 
prescribed before or after conservative management, 53.3% did not receive any 
opioids, 23.3% of patients received an opioid prior to conservative management 
and 23.3% received an opioid after conservative management was tried.   
CDC recommendations include the use of a controlled substance 
agreement (CSA) and while 52.9% of the providers did not use a CSA because no 
opioids were prescribed, 28.7% did utilize a CSA prior to prescribing opioids and 
18.3% did not obtain a CSA prior to initiating opioids.  The use of prescription 
drug monitoring programs (PDMP) are also recommended and 52.9% of the 
providers did not consult the PDMP because they did not prescribe an opioid, 
27.9% did not consult the PDMP prior to initiating an opioid and 19.2% of the 
providers did utilize the PDMP.  Urine drug screening (UDS) is another 
recommendation when prescribing opioid therapy and while 52.9% of the 
providers did not obtain a UDS because they did not prescribe opioids, 29.6% of 
the providers did obtain a UDS and 17.5% did not obtain a UDS. 
Hydrocodone or oxycodone were utilized for pain management within the 




were provided fentanyl, 2.1% were given morphine, 2.1% were given both 
hydrocodone and morphine, 0.4% were provided fentanyl and morphine and 
53.3% did not receive any opioids.  CDC guidelines recommend using the lowest 
effective dose if pain is going to be managed with an opioid. An initial dose 
hydrocodone 5 mg or oxycodone 10 mg was given to 41.3% of patients, 2.1% 
received a dose of 5/10/15 or 30 mg of morphine for an initial dose, 2.1% 
received 5 mg of morphine and 5 mg of either hydrocodone or oxycodone as an 
initial dose, 0.4% received 50 mcg of fentanyl and 30 mg of morphine as an initial 
dose while 54.2% did not receive any opioid therapy.   
Regional Data 
Regional data was retrieved from the Kansas Epidemiological Data 
Dashboard and it was broken down into counties 
(http://www.preventoverdoseks.org/kpdo_data.htm). The researcher took the data 
from each county in each region of Kansas and compiled the data to reflect the 
region.  The most recent data available was from 2017 and the information looks 
at each region of Kansas but does not reflect any one clinic or set of clinics in the 
other regions.  
The information for each region is the number of opioids per 100 persons 
in the region.  The Kansas City Metro region had the lowest number of opioids at 
96.13 opioids per 100 persons. The Southwest region came in with the next 
lowest at 110.2 opioids per 100 persons. The Northeast region in Kansas held the 
third lowest number of opioids with 112.605 opioids per 100 persons. The 




Central region had 124.03 opioid per 100 persons while the South-Central region 
has 136.73 opioids per 100 persons. The Southeast Kansas region overall had the 
highest number of opioids with 157.858 opioids per 100 persons.  This data 
clearly identifies that Southeast Kansas has the largest number of opioids per 100 
residents than the other regions in the state of Kansas, however, in the clinic that 
this researcher looked at, just over one half of the providers in the clinics did not 
prescribe opioids for acute or chronic back pain.   
Summary 
The purpose of this study was to see if providers within a set of clinics in 
the Southeast Kansas area were contributing to the opioid problem in the US with 
inappropriate prescribing practices compared to other regions in Kansas.  The data 
clearly indicates that Southeast Kansas has the highest number of opioids per 100 
persons compared to other regions in the state, however, this researcher was only 
able to gather data from one set of clinics in the Southeast Kansas region, and the 
information revealed that more than half of the providers did not prescribe an 
opioid to patients for management of acute or chronic back pain. The data 
obtained unfortunately does not provide information regarding various clinics 
across the other regions of Kansas.  Within the clinics that were researched, just 
over 50% of the providers followed CDC guidelines for the safe prescribing of 
opioids while just over 25% of the providers obtained a CSA and obtained a UDS. 

















Discussion of Findings, Recommendations and Conclusions 
 
 
The purpose of this scholarly project was to determine if a set of clinics in 
Southeast Kansas may be contributing to the opioid epidemic and then compare 
Southeast Kansas’ opioid use to other regions in Kansas.  The data retrieved from 
the clinics in Southeast Kansas looked to see if providers within the clinic were 
following CDC guidelines when prescribing opioids for acute or chronic low back 
pain.   
Chronic pain management can be challenging for providers that have 
specialized in pain therapy, much less for providers that lack formal education.  
Opioids should not be the initial medication provided to patients with chronic 
pain.  Different types of pain are treated with various medications and are often 
treated more effectively with non-opioid pharmacological therapy.  Treatment of 
pain is not a one drug fits all category and each patient should be evaluated 
independently regarding the type of pain they have and ascertain the best 
approach to treatment that carries the least amount of side effects for the patient.   
Roughly 25 million adult Americans experience pain every day and about 
23 million more endure relentless pain causing debilitation, loss of job 




is a societal issue and the misuse of drugs is among the 25 leading causes of the 
death in the world (Beneitez, 2017).   
The best approach to chronic pain including both acute and chronic low 
back pain is a multidisciplinary method encompassing psychological, physical, 
cognitive-behavioral therapies that focus on respite and coping mechanisms with 
self-hypnosis (Meldrum, 2016).  Managing chronic noncancer pain in individuals 
with substance abuse disorders can be slightly more challenging for providers, but 
following recommended guidelines, professionals can carefully and successfully 
treat these persons for their pain and their addiction.  
            Research Questions and Relationship of Outcomes to Research 
The CDC recommended guidelines include the use of nonpharmacological  
and nonopioid therapy as first-line treatment to include ibuprofen, Tylenol, ice, 
heat , physical therapy or a combination of each, education provided to patients 
regarding goal expectation and opioid use-risks versus benefit, if an opioid was 
prescribed, was it before or after conservative management, the choice of the 
opioid and dose provided, use of a controlled substance agreement, use of 
prescription drug monitoring programs (PMDP); and periodic drug screenings to 
verify compliance and deter abuse and misuse.  
Demographic information obtained on the providers in this study revealed 
that the average age of the provider was 48.5 years, with 73.3% of the providers 
being female compared to 26.7% male providers and the average years in practice 
was 12.3 years.  The age of the provider is consistent with other research 




with other research is the provider gender, which is the opposite from Keller’s 
(2012) study where 71% of providers were male.  The average number of years in 
practice of this study (12.3 years) was slightly lower than Keller’s (2012) study 
which had an average of 18.5 years in practice.  
Patient demographics was also looked it and this study showed the 
average age of the patient receiving opioid therapy was 48.07 years.  The largest 
grouping of individuals ranged between 25-70 years of age (Keller, 2012).  This is 
consistent with other research conducted showing the average age of patient 
receiving opioid therapy between the ages of 19-40 at 20.4%, 28.3% of 
individuals between the ages of 41-65 years of age, and 35.3% of individuals 
receiving opioid therapy over the age of 65 (Keller, 2016).  The most recent data 
reviewed by the CDC indicates that the largest group of individuals receiving 
opioid therapy between the ages of 25-40 years of age (CDC, 2017).  
Patient gender in this study indicated that 54.2% of females received 
opioids which was consistent with 61.2% females found in the study done by 
Keller (2012).  This was inconsistent with the most recent data from the CDC 
revealing that 55.6% of males received opioids compared to 44.4% of females.  
Patient ethnicity was also gathered in this study and revealed that 80.4% 
of patients receiving opioids were Caucasian, followed by 4.2% African 
American, 4.2% Native American and 3.3% Hispanic with 0.8% identifying as 
Caucasian/Hispanic.  This was partially consistent with other research that 
indicated 59.9% of opioid recipients were Caucasian, 27.4% African American, 




2012).  This study was also somewhat consistent with the most recent CDC data 
which revealed 8,128 Caucasian individuals receiving opioids, 1,400 African 
Americans and 2,156 Hispanics receiving opioids (CDC, 2017).  
This study also revealed that of the individuals receiving opioid therapy, 
70.4% held some form of insurance compared to 29.6% that were uninsured.  This 
data was consistent with other research revealing that more than three-fourths of 
individuals receiving opioids held some type of insurance and only 4.6% of 
persons being uninsured (Keller, 2012).  Data retrieved from the CDC broke this 
information down into an estimation of the percentage of persons that had a drug 
related hospitalization or emergency room visit based off insurance and showed 
that 84.3% of individuals that were hospitalized with a drug related event or 
visited the emergency room due to a drug related event held some form of 
insurance (CDC, 2017).  
The results of this study were consistent with prior studies indicating that 
pain management is primarily provided by family practice providers followed by 
internal medicines providers.  Nurse practitioners and physician assistants 
prescribe more opioids than pain management specialists (Kaye, 2017).  Seventy 
percent of the providers in this study were family practice, and 16.7% were 
internal medicine.  Of the 70% of family practice providers, 53.3% were nurse 
practitioners followed by 33.3% of medical physicians.  
Considering formal pain management education during training, the 
results of this survey are consistent with prior research.  The survey revealed that 




formal education while 3.3% report receiving formal education with pain 
management. In one research study completed in 2009 in which more than 30 
physician organizations, revealed that education for pain management was 
inadequate and did not lead to proficiency (Pizzo, 2012). While not required and 
not a formal form of education, the results of this study did reveal that of the 
providers that answered the question, 20% reported that they had taken some 
continuing education classes specifically geared toward pain management 
compared to 6.7% that had not taken any classes, however 26.7% chose not to 
answer the question.   
There are a finite number of pain specialists available making primary 
care providers ideally responsible for providing pain management to patients.  
However, if education and training is not restructured, effective pain management 
will continue to be a challenge.  Providing education for primary care providers 
can increase patient outcomes through a more comprehensive understanding of 
pain, prevention and treatment of pain with further knowledge on avoiding abuse 
and misuse of medication.  
Conservative management of acute and chronic low back pain has been 
shown to be more effective than opioids, and studies have revealed that non-
steroidal anti-inflammatory drugs (NSAIDS) acetaminophen and aspirin are 
frequently provided (Chou, 2007).  The results of this study revealed that 82.1% 
of providers in the clinic, initiated treatment with an NSAID, sometimes coupled 
with physical therapy, ice or heat treatment.  This follows the CDC recommended 




or chronic. This study also revealed that 53.3% of clinic providers followed the 
recommended guidelines and did not prescribe opioids to their patients, yet 23.3% 
of the providers prescribed opioids prior to the use of conservative management; 
and 23.3% prescribed opioids after trialing conservative management.  
When prescribing opioids, the lowest effective dose for the shortest 
amount of time should be prescribed if the provider is following the 
recommended CDC guidelines.  This study revealed that 53.3% of providers 
followed guidelines by not prescribing opioids, and although it is recommended 
that providers begin opioid dosing with the lowest dose, this study found that 
hydrocodone was initiated at the lowest dose of 5/325 mg, oxycodone was 
initiated at the higher dose of 10/325 mg. Morphine alone or a combination of 
morphine and either hydrocodone or oxycodone were the next most frequent 
initial prescriptions.  Morphine alone was given at a dose of 5mg or 30 mg as the 
most prescribed initial dose while the combination of morphine and hydrocodone 
of oxycodone dose was 5mg and 5 mg combined. The lease prescribed initial 
treatment was a combination of fentanyl and morphine at 0.4% with an initial 
dose of 50mcg and 30 mg respectively.  
CDC guidelines also recommend that providers consult the prescription 
drug monitoring program (PDMP), obtain a urine drug screen (UDS) and a 
controlled substance agreement (CSA) if opioid therapy is initiated.  Though 
52.9% of providers did not prescribe opioids, 27.9% of providers that did 
prescribe opioids did not consult a PDMP first. Continuing with CDC 




prescribing while 17.5% did not obtain a UDS prior to prescribing an opioid.  
Lastly, still following CDC guidelines, of the providers that wrote a prescription 
for an opioid, 28.7% of providers obtained a CSA prior to the prescription while 
18.3% did not obtain a CSA when prescribing an opioid.  
A key benefit to improving the outcome of a patient suffering from 
chronic pain is education that incorporates the individual’s thoughts regarding 
pain, their expectation for pain control and any concerns they have.  Of the 
providers that did prescribe an opioid, 33.8% of providers did not educate their 
patient regarding opioid therapy and the dangers of opioid therapy while 13.8% of 
the providers did provide the patient with education.   
The clinics used in this study revealed that more than one-half of the 
providers were consistently following the recommended CDC guidelines, 
however, regional data showed that Southeast Kansas has the highest number of 
opioids per 100 residents at 157.858 opioids per 100 residents. Comparing other 
regions in Kansas to the Southeast Kansas region, Southeast Kansas has a long 
way to go to help curb the opioid epidemic compared to other regions in Kansas.  
The Kansas City Metro region and the Southwest region held the lowest rate of 
opioids per 100 residents. The regional data was retrieved from the Kansas 











Educational Policy Implications 
This study reveals that pain management is challenging even for providers 
that specialize in pain, more so for providers in family practice or internal 
medicine that receive little formal education in pain management.  Health 
outcomes for patients would benefit immensely from educated providers 
regarding pain and the most effective treatment available.  Better provider 
education would not only improve outcomes but would reduce costs associated 
with drug related overdose and emergency room visits, patient abuse, diversion of 
opioids and patient satisfaction as well.  
           Policy Implications 
The tendency for providers to overprescribe or under-prescribe medication 
for pain leaves providers in a quandary. With reimbursement tied to patient 
satisfaction, not treating a patient’s pain results in a poor satisfaction score for 
providers, yet over-prescribing for pain leads them to open to litigation even 
under the best of intentions, simply due to lack of formal education.   
Research clearly shows that treatment with NSAIDs, acetaminophen, ice, 
heat, and physical therapy are superior to treatment with opioids for acute and 
chronic back pain, and insurance companies should recognize this benefit and be 
supportive of conservative management in patients.  A reduction in opioid use not 
only improves patient outcomes, but reduces the annual cost associated with 






Two theoretical models were used for this study and included Patricia 
Benner’s theoretical model, From Novice to Expert (1984) and Nola Pender’s 
(1982) Health Promotion Model.  With Patricia Benner’s theoretical manner, the 
new provider grows in practice through exploration, repetition and employment of 
evidence-based skills, the provider progresses from conceptual principles to 
perception and proficiency.  Applying and developing knowledge are the result of 
practice that links theory to research (Moran, 2017).  Utilizing knowledge, 
experience and evidence-based practice allows the clinician to improve the care 
provided to patients.    
Nola J. Pender’s Health Promotion Model is applicable when considering 
how an individual’s surroundings and upbringing can influence the decisions that 
persons makes, how individuals achieve their dreams, and the obstacles that either 
hinder or entice them.  Providers are role models to other people and promote 
healthy behaviors through education.  If health disparities increase the likelihood 
that an individual will become addicted to prescription pain medication, then 
providers need to be more cognizant of how they prescribe and become better 
stewards of the community with an emphasis on health promotion.  Promotion of 
health through education within the community will allow the provider crucial 
experiences in knowledge but offers the opportunity for them to be role models 
and improve the life of others before chronic illness and poor lifestyle choices 






Knowledge of the pathophysiology of pain can guide the provider into an 
appropriate diagnosis for the patient. However, due to the chronic and often 
coinciding factors, the diagnostic work-up can be challenging for even the more 
experienced clinician.  The clinician cannot just simply perform a quick 
assessment and come to a diagnosis it often requires detailed history and a 
thorough physical exam and imaging to be done. An effective history and 
physical exam for a pain visit can often take more time than the allotted 20 
minutes allowed for each visit. The use of validated tools to assess pain should be 
used at each visit (Leonardi, 2015).   
While diagnosing a patient’s pain can be challenging, coming up with an 
appropriate treatment plan can be equally as trying.  The history of the pain, prior 
treatments, detailed medical history, the age of the client, the gender, social, 
cultural and psychological factors all need to be carefully considered.  A detailed 
conversation regarding the patient’s expectation for pain management should be 
reviewed, and the care should be focused on the patient.  
Research has clearly shown that for acute and chronic pain, multiple 
nonpharmacological and non-opioid pharmacologic treatments were most 
effective especially if coupled with exercise therapy.  A multi modal treatment 
plan ideally will allow the individual to function better enabling them to lead a 
healthier lifestyle which in turn improves one’s quality of life.  
The goal in performing a retrospective chart review of providers practices 




may be contributing to the opioid epidemic through failure to follow CDC 
recommendations.  The CDC guidelines are intended to keep patients safe while 
guiding clinicians in how to prescribe opioids if necessary. Research clearly 
indicates that more than 50% of controlled substances are prescribed by primary 
care providers which is consistent with the results of this study revealing 70% of 
providers practiced in family medicine (Carter, 2017).   
Provider demographics in this study showed the average age of the 
provider to be 48.5 years, a higher percent of female providers at 73.3% and the 
average years in practice at 12.3 years.  The average age of the provider is 49.1 
years (Keller, 2012).  This research revealed a higher number of female providers 
with fewer years in practice at 12.3 years compared to prior research showing 
71% of providers as male and an average of 18.5 years in practice (Keller, 2012). 
Patient demographics for this research revealed the average age of the 
patient receiving opioids to be 48.07 years which is comparable to previous 
research showing 20.4% of patients between the ages of 19-40 years, 28.3% of 
patients between 41-65 years and 35.3% of patients over the age of 65 receiving 
opioids (Keller, 2012).  This study revealed more females (61.2%) receiving 
opioid therapy compared to prior research 54.2% (Keller, 2012).  Ethnicity of the 
patient showed 80.4% of patients receiving opioids identifying as Caucasian 
compared 59.9% with Keller’s (2012).  Demographic location could account for 
this difference between these numbers.  Individuals with insurance also held a 




insurance which is consistent with prior studies showing that only 4.6% of 
individuals were uninsured (Keller, 2012).  
Providers prescribing medications for chronic pain should feel 
comfortable and have adequate training in the pathophysiology of pain and the 
appropriate therapy to treat specific types of pain.  Research shows that primary 
care providers do not feel as though they received sufficient education regarding 
pain management and are not certain of their competence when prescribing pain 
medications (Keller, 2012).  This study shows that of the providers that answered 
the question about receiving education in pain management less than one quarter 
(23.3%) reported that they did not receive formal education and, only 3.3% did 
receive education in pain management.  
The CDC recommended guidelines clearly indicate that non-
pharmacological, non-opioid therapy should be initiated prior to initiating 
treatment with opioids; however, once the decision to prescribe opioids has been 
made, the clinician is best served by obtaining a urine drug screen, consulting 
with a prescription drug monitoring system, having a frank conversation 
regarding the potential harm of opioid therapy with the patient and obtaining a 
controlled substance agreement with the patient (Dowell, 2016).  This study 
reveals that 78.3% of providers did follow CDC guidelines and did not prescribe 
opioid therapy. Of the clinicians that saw patients with a diagnosis of acute and/or 
chronic back pain, 82.1% of them prescribed non-pharmacological, non-opioid 
therapy to persons with acute and/or chronic back pain. Once the provider in this 




substance agreement, 27.9% did not consult a prescription drug monitoring 
database and 29.6% did obtain a urine drug screen. Providing education to the 
patient regarding the hazards of opioid therapy is critical when prescribing 
opioids, and this study revealed that of the providers that prescribed opioids 
33.8% did not provide education to the patient.  
Regional data from the Kansas Epidemiological Data Dashboard clearly 
indicates that Southeast Kansas holds the highest number of opioid prescriptions 
per 100 residents compared to the other regions in Kansas.  This study shows that 
53.3% of providers did not prescribe opioids for the treatment of acute or chronic 
back pain, when an opioid was prescribed, more than 25% did not consult a 
prescription drug monitoring database.  This is an effective tool in identifying 
potential opioid users, abusers and diverters and can be beneficial in guiding 
providers in their decision making. More than 25% of the providers in this study 
did obtain a controlled substance contract and/or a urine drug screen if an opioid 
was prescribed which is another useful tool for identifying potential opioid 
abusers or diverters.   
Logic Model   
The logic model designed for this study reveals how family practice 
providers may contribute to the opioid epidemic through their prescribing 
practices. The logic model also reveals how CDC recommendations regarding 
treatment of chronic pain and opioid prescribing practices among primary care 
providers can decrease the opioid epidemic with prescription drug monitoring 




of the CDC guidelines can help providers identify potential opioid abusers and 
diverters enabling them to appropriately treat the patient even if that requires 
getting them assistance for an abuse problem.  This study clearly indicates that the 
logic model will improve patient outcomes through safe prescribing practices 
among providers, increasing collaboration among providers, identifying potential 
abusers sooner and increasing patient knowledge regarding the dangers of long 
term opioid use.  
Limitations 
Possible limitations to this study include the limited number of clinics and 
time that was studied which may not lead to a representative sample of the 
information being sought.  This study included only individuals with a diagnosis 
of acute or chronic low back pain however; when looking at pain, all chronic pain 
minus pain related to cancer could yield a difference in the outcome of the study.  
Including only acute and or chronic back pain for this study leaves it open for 
scrutiny on the reliability of regional comparison across the state of Kansas.   
Medicine and treatment modalities are never stagnant, and knowledge in 
medicine changes rapidly.  The evolving nature of medicine may interfere with 
new knowledge that is identified to date.  Looking at regional data is an 
informative indicator of how one region in Kansas compares to other regions 
however; this study only looked at one set of clinics in Southeast Kansas, and a 
better representative sample would need to include different clinics across all 





Recommendations for Future Research 
Future research for the opioid epidemic should look at clinics from all 
areas in the state of Kansas and then compare that data to regional clinics which 
would yield a better representation of regional data.  Future research could also 
look at providers and compare medical doctors to doctors of osteopathy to nurse 
practitioners and physician assistants to identify those that may be over-
prescribing opioids.  This data can then be looked at regionally to note differences 
among providers and prescribing practicing, educational training among different 
providers and the level of education received.   
Study results reveal that providers may inadvertently be contributing to the 
opioid epidemic due to lack of education regarding pain management during 
formal education or because CDC guidelines have not been followed, leading to 
inability to identify potential users and diverters of opioids.   
There is no question that opioids are an effective treatment for acute and 
or chronic back pain if conservative management fails, however; pain 
management becomes challenging when the nation is currently faced with an 
epidemic of enormous proportions due to drug use.  When reimbursement is 
linked to patient satisfaction, and opioids can and are used for legitimate 
purposes, many providers are placed in a sticky situation regarding treatment 
modalities.  Providers become afraid to prescribe thereby under-prescribing for 
fear of legal retribution or over-prescribing due to lack of knowledge in pain 




appropriate care based on clinical practice guidelines however; these guidelines 
may not correspond with patient satisfaction.   
Conclusions 
Chronic pain is an extensive challenging health problem that creates 
enormous personal and socioeconomic costs (Peters, 2017).  Unrelenting pain is 
associated not just with physical ailments but emotional suffering, and individuals 
often carry a diagnosis of depression due to chronic pain (Peters, 2017).  Pain 
management can only be successful in persons suffering with pain if they are 
taught coping mechanisms allowing them to adapt to the devastating effects 
(Peters, 2017). 
Clinical practice guidelines are recommendations for providers to improve 
patient outcomes by guiding their decision making for various treatments, 
including those involving both acute and chronic back pain.  The treatment of 
pain either acute or chronic, is complex at best and needs to have a 
multidisciplinary approach, but without proper education and a lack of pain 
specialists, primary care providers have been forced to become pain management 
specialists placing them in a precarious position of treating patients for complex 
pain without appropriate education in treating pain.  Even with appropriate 
training in pain management for clinicians, there are several individuals that 
obtain pain medications illegally which makes treating individuals with chronic 
pain more challenging.  This also requires clinicians to be more vigilant, if 




appropriately treating the patient and maintaining patient satisfaction (Couto, 
2009).  
Additional education for primary care providers would enhance their 
knowledge about pain and how to appropriately manage pain, the pharmacology 
of opioids and addiction (Volkow, 2011).  The education is imperative for 
primary care providers as research clearly indicate that primary care providers 
prescribe more opioids than other practicing providers (Volkow, 2009).  Formal 
education in pain management should also include evidence-based 
recommendations regarding treatments approaches for persons with current opioid 
addictions and other comorbidities (Keller, 2012).   
The clinical guidelines put forth by the CDC supplement other approaches 
such as reinforcing evidence base for deterring and treating pain, minimizing 
inequalities in pain management, enhancing service administration and 
compensation and substantiating public and professional education (Dowell, 
2016).  
           Summary 
Pain is very much individualized and subjective, and how people cope 
with pain is very diverse, making the treatment of noncancer related pain and 
specifically acute and chronic back pain acute more complex and challenging.  
Treatment for such pain should be a multidisciplinary approach with patient 
engagement and improved education provided to the patient regarding different 
types of pain, and the best methods for managing their pain.  Most often acute and 




can spend time with the patient providing much needed education.  Providers 
need to be well-versed in the different types of pain and how to treat as well.  
Lack of provider education regarding the treatment of acute and/or chronic 
back pain and chronic noncancer pain, lack of knowledge among lay persons 
regarding the pathophysiology of pain, bringing about pain as the fifth vital sign, 
advising people that they have the right to have their pain treated, and tying 
reimbursement to patient satisfaction, created an unrealistic expectation for 
individuals suffering from pain.   
The first rule of medicine is to do no harm, and providers want what is 
best for their patient however; the lack of education, lack of knowledge, 
reimbursement, and providers wanting to keep patients satisfied have all 
contributed to the current epidemic we are facing through over-prescribing or 
under-prescribing.  With unrealistic expectations for pain control, individuals 
began to self-treatment with opioids contributing to the misuse and abuse of 
opioids and the crisis facing our nation spun out of control.   
Opioids have been shown to be effective; however due to the recent 
epidemic plaguing this nation due to misuse and abuse, providers and patients 
need to become better team members to combat this epidemic.  Opioids will 
always be around as they have a place in pain management, and misuse and abuse 
will always occur to some extent; however, as providers it is our responsibility to 
our patients, their families and the communities that we live in to protect them 
from danger, and this includes the misuse of drugs, and as good stewards we are 




education of ourselves, our colleagues, education to patients and prescribing 
practices that follow recommended guidelines that improve the safety of our 
patients.   
This epidemic did not begin over-night and it will not be fixed over-night 
but if we want to combat this rapidly growing plague facing this nation, we must 
begin now, and continue to be vigilant to protect our patients, families and 
communities that we live in.  Combatting this epidemic needs to be a team effort 
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